martes, 9 de diciembre de 2025

Structure reports promising weight loss outcomes with obesity drug, but side effect questions loom Structure’s drug is a small molecule pill, which comes with manufacturing advantages and convenience for patients

https://www.statnews.com/2025/12/08/structure-obesity-oral-small-molecule-aleniglipron-side-effects/ By Elaine ChenDec. 8, 2025 National Biotech Reporter

No hay comentarios: